Matches in UGent Biblio for { <https://biblio.ugent.be/publication/3136236#aggregation> ?p ?o. }
Showing items 1 to 37 of
37
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B510860.
- aggregation creator B510861.
- aggregation creator B510862.
- aggregation creator B510863.
- aggregation creator B510864.
- aggregation creator person.
- aggregation date "2012".
- aggregation format "application/pdf".
- aggregation hasFormat 3136236.bibtex.
- aggregation hasFormat 3136236.csv.
- aggregation hasFormat 3136236.dc.
- aggregation hasFormat 3136236.didl.
- aggregation hasFormat 3136236.doc.
- aggregation hasFormat 3136236.json.
- aggregation hasFormat 3136236.mets.
- aggregation hasFormat 3136236.mods.
- aggregation hasFormat 3136236.rdf.
- aggregation hasFormat 3136236.ris.
- aggregation hasFormat 3136236.txt.
- aggregation hasFormat 3136236.xls.
- aggregation hasFormat 3136236.yaml.
- aggregation isPartOf urn:issn:1473-7167.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany".
- aggregation abstract "To assess the comparative public health and budget impact over 5 years of several pneumococcal vaccination strategies (23-valent pneumococcal polysaccharide vaccine [PPV23] and/or 13-valent pneumococcal conjugate vaccine [PCV13]) in Germany, within the context of changing invasive pneumococcal disease (IPD) incidence over time. A multi-cohort, population-based Markov model was developed. Uncertainty around vaccine effectiveness, costs and IPD incidence change was handled through scenario analyses. Between 2012 and 2016, the introduction of PCV13 in adults, compared with the use of PPV23, would be associated with a net estimated budget increase of (sic)59.7 million (+6.7%) to (sic)151.6 million (+13.7%). Impact on IPD incidence ranged from -113 cases (-0.8%) to +298 cases (+2.8%). Introducing PCV13 in adults is expected to significantly affect healthcare budgets. Adult vaccination with PPV23 remains the optimal vaccination strategy from public health and budget perspectives.".
- aggregation authorList BK856566.
- aggregation endPage "643".
- aggregation issue "5".
- aggregation startPage "631".
- aggregation volume "12".
- aggregation aggregates 3144933.
- aggregation isDescribedBy 3136236.
- aggregation similarTo ERP.12.55.
- aggregation similarTo LU-3136236.